Eckuity Capital

Profile

Eckuity Capital is a healthcare growth equity firm based in New York, London, and Miami, founded in 2021 by Youssef Sebban, who serves as the Managing Partner. The firm specializes in providing both capital and operational support to commercial-stage companies. Eckuity's team, including newly added partners Paul Enever and Alejandro Sanchez, boasts significant experience in medical technology and healthcare investments, focusing on companies that have achieved regulatory approval but need support to scale. The firm's network of venture partners and an advisory board further enhances its capabilities to create value in the healthcare sector.

Eckuity Capital primarily invests in commercial-stage life sciences sectors, focusing on medical technology, diagnostics, and tech-enabled healthcare services. They target North America and Western Europe, typically engaging in Series C rounds and beyond, with a practice of leading rounds. Their approach involves a proprietary commercialization platform designed to help companies bridge the gap between regulatory approval and market leadership. Eckuity’s initial fund was fully deployed across 14 companies, and their second fund is continuing this strategy by investing in companies with regulatory clearance and scalable market strategies.

Among Eckuity Capital’s notable portfolio companies are Automata Technologies, which they led in a Series C round, as well as Ansella, Avive, Kardium, and Samsara Vision, each playing a role in advancing various healthcare technologies and services. Eckuity's emphasis on commercialization and scaling capabilities distinguishes their approach, making them a strategic partner for emerging healthcare leaders.